Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in CRSP — CRISPR Therapeutics AG

CIK 886982 NEW YORK, NY
Back to CRSP Full portfolio

Position in CRSP

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$19,704,444
+$5,250,303 QoQ
Shares Held
414,220
+50.3% QoQ
Ownership
0.429%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99.92105644343584.ToString("F0")% Shared 0.ToString("F0")% None 0.07894355656414466.ToString("F0")%

Common Shares in CRSP Over Time

Shares Held

Position Value (USD)

Derivatives in CRSP

reported options exposure · as of Sep 30, 2025
CallValue
$1,510,073
CallShares
23,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. CRSP ranks #105 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,417,875 $1,079,677,898
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,300,558 $1,004,863,129
3 MRNA
Moderna, Inc.
 6,603,697 $335,467,805
4 ROIV
Roivant Sciences Ltd.
 11,111,591 $307,791,069
5 PRAX
Praxis Precision Medicines, Inc.
 710,734 $228,991,385
6 INCY
Incyte Corp
 2,351,221 $221,296,919
7 RVMD
Revolution Medicines, Inc.
 2,185,500 $212,539,874
8 RYTM
Rhythm Pharmaceuticals, Inc.
 1,965,432 $170,933,620

All Filings in CRSP

Export CSV
38 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $19,704,444 414,220
2025-12-31 $14,454,141 275,632
2025-09-30 $1,510,073 23,300
2025-09-30 $15,135,856 233,542
2025-06-30 $1,133,312 23,300
2025-06-30 $10,729,983 220,600
2025-03-31 $5,013,571 147,328
2024-12-31 $7,764,704 197,274
2024-09-30 $9,858,283 209,840
2024-06-30 $14,331,390 265,347
2024-03-31 $9,044,627 132,697
2024-03-31 $511,200 7,500
2023-12-31 $1,821,660 29,100
2023-12-31 $11,745,011 187,620
2023-09-30 $3,222,690 71,000
2023-09-30 $5,630,402 124,045
2023-06-30 $7,718,407 137,485
2023-06-30 $3,985,940 71,000
2023-03-31 $3,211,330 71,000
2023-03-31 $10,740,044 237,454
2022-12-31 $20,212,521 497,233
2022-12-31 $6,776,355 166,700
2022-09-30 $48,744,956 745,906
2022-09-30 $21,467,475 328,500
2022-06-30 $8,720,495 143,500
2022-06-30 $30,093,668 495,206
2022-03-31 $7,318,792 116,597
2021-12-31 $6,062,400 80,000
2021-12-31 $11,684,215 154,186
2021-09-30 $36,722,218 328,082
2021-06-30 $12,413,886 76,681
2021-03-31 $12,230,449 100,373
2021-03-31 $1,608,420 13,200
2020-12-31 $1,408,612 9,200
2020-12-31 $17,759,228 115,990
2020-09-30 $6,434,174 76,927
2020-06-30 $8,088,162 110,058
2020-03-31 $4,427,645 104,401

Report a Problem

Category
Description
Email (optional, for follow-up)